Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment.
Cancer Genet Cytogenet
; 162(1): 57-62, 2005 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-16157201
Search on Google
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Fusion Proteins, bcr-abl
/
Genes, MDR
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Genet Cytogenet
Year:
2005
Type:
Article
Affiliation country:
Italy